| Literature DB >> 35627127 |
Jose Carlos Solana1,2, Lorena Bernardo2,3, Javier Moreno2,3, Begoña Aguado4, Jose M Requena1,2.
Abstract
Abrupt environmental changes are faced by Leishmania parasites during transmission from a poikilothermic insect vector to a warm-blooded host. Adaptation to harsh environmental conditions, such as nutrient deprivation, hypoxia, oxidative stress and heat shock needs to be accomplished by rapid reconfiguration of gene expression and remodeling of protein interaction networks. Chaperones play a central role in the maintenance of cellular homeostasis, and they are responsible for crucial tasks such as correct folding of nascent proteins, protein translocation across different subcellular compartments, avoiding protein aggregates and elimination of damaged proteins. Nearly one percent of the gene content in the Leishmania genome corresponds to members of the HSP40 family, a group of proteins that assist HSP70s in a variety of cellular functions. Despite their expected relevance in the parasite biology and infectivity, little is known about their functions or partnership with the different Leishmania HSP70s. Here, we summarize the structural features of the 72 HSP40 proteins encoded in the Leishmania infantum genome and their classification into four categories. A review of proteomic data, together with orthology analyses, allow us to postulate cellular locations and possible functional roles for some of them. A detailed study of the members of this family would provide valuable information and opportunities for drug discovery and improvement of current treatments against leishmaniasis.Entities:
Keywords: HSP40; J-domain protein (JDP); Leishmania; molecular chaperones
Mesh:
Substances:
Year: 2022 PMID: 35627127 PMCID: PMC9141911 DOI: 10.3390/genes13050742
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.141
Figure 1Overview of the HSP70/HSP40 chaperone system. An unfolded protein (the substrate) binds to an HSP40 member, and both form a complex with the HSP70 chaperone in its ATP-state, which has low affinity for polypeptides. The HSP40–HSP70 interaction triggers ATP hydrolysis and promotes a conformational change in the HSP70 (ADP-bound state) that results in a structure with high affinity for the protein substrate, which is bound into the substrate binding domain (SBD) of HSP70. Following substrate transfer, HSP40 leaves the complex, and the nucleotide exchange factor (NEF) is recruited to the HSP70–polypeptide complex, stimulating the ADP-by-ATP exchange. ATP binding induces both release of NEF and the folded polypeptide and leaves HSP70 ready for a new cycle.
Figure 2Classification of HSP40s into four types and representative L. infantum proteins for each type. (A) Type I proteins have in their structure the four typical domains, starting with a J-domain in the N-terminal end and a short G-F-rich region, followed by a zinc-binding domain that ends in the substrate-binding C-terminal domain. Type II proteins share the J-domain and the G-F-rich linker but lack the zinc-finger domain. Type III proteins show remarkable structure divergence and only share the J-domain, which is frequently located in the middle of the sequence. Type IV HSP40s include those proteins lacking the highly conserved HPD motif in their J-domains; the zinc-binding domain is absent in some type IV proteins. (B) Protein structure of representative members of the HSP40 family in L. infantum. The J-domain consists of four α-helices. The G-F-rich linker is followed by two β-sandwich C-terminal domains which contain four repeats of the CxxCxGxG motif (zinc finger region) and a dimerization domain that is involved in binding to client polypeptides.
Figure 3Phylogenetic relationships among L. infantum HSP40 proteins. The evolutionary history was inferred by using the Maximum Likelihood method and JTT matrix-based model [35]. The tree with the highest log likelihood (-96100,93) is shown. Initial tree(s) for the heuristic search were obtained automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using the JTT model, and then selecting the topology with superior log likelihood value. This analysis involved 72 amino acid sequences, and the tree was inferred from 1000 replicates. There were a total of 2470 positions in the final dataset. Bootstrap values lower than 50% are not indicated. Evolutionary analyses were conducted in MEGA11 [36]. Color codes denote the HSP40 classification: type I (green), type II (blue), type III (orange), type IV (violet), not applicable (black).
L. infantum HSP40 proteins.
| Name | Gene ID | Size | J-Domain | G/F Rich | Zn-Finger | Type | Remarks a |
|---|---|---|---|---|---|---|---|
| J1 | LINF_320037800 | 329 | 14–80 | - | - | III | - |
| J2 | LINF_270032200 | 396 | 6–72 | 78–94 | 120–205 | I | - |
| J3 | LINF_210010300 | 453 | 6–72 | 83–99 | 125–210 | I | - |
| J4 | LINF_150019800 | 478 | 6–72 | 81–97 | 144–227 | I | - |
| J5 | LINF_360019000 | 364 | 86–180 | 161–183 | - | II | Transmembrane domains (192–215, 229–252). |
| J6 | LINF_360072700 | 345 | 4–70 | 124–140 | - | II | - |
| J7 | LINF_320025300 | 323 | 9–75 | 91–107 | - | II | - |
| J8 | LINF_240010000 | 794 | 42–108 | - | - | III | Signal peptide (1–24). |
| J10 | LINF_170010900 | 157 | - | - | - | - | Possibly mis-annotated (see text). HPD motif (5–7). Transmembrane domains (76–99, 113–136). |
| J11 | LINF_040012900 | 576 | 9–75 | - | - | III | Transmembrane domains (90–113, 127–150, 162–185, 194–217, 294–317, 346–369, 422–442, 461–484). |
| J13 | LINF_180020400 | 184 | 14–80 | - | III | - | |
| J14 | LINF_080014500 | 326 | 21–79/157–223 | - | - | III | Two J-domains. |
| J15 | LINF_190005600 | 432 | 5–71 | 128–149 | - | II | - |
| J16 | LINF_200016400 | 653 | 140–206 | 228–240 | - | II | SANT/Myb SANT/Myb domain (513–567). |
| J17 | LINF_120015200 | 608 | 4–70 | 64–126 | - | II | - |
| J18 | LINF_270009200 | 378 | 73–139 | - | - | III | Transmembrane domains (330–353, 359–377). |
| J19 | LINF_340048600 | 266 | 24–85 | 94–142 | - | II | Transmembrane domain (129–152). |
| J20 | LINF_360011700 | 260 | 171–237 | - | - | III | J-domain at C-terminus. |
| J21 | LINF_260019100 | 536 | 405–471 | - | - | III | J-domain at C-terminus. Transmembrane domain (491–514). |
| J22 | LINF_360028100 | 286 | 21–87 | 84–139 | - | II | Transmembrane domain (149–172). |
| J23 | LINF_180008300 | 244 | 49–115 | - | - | III | Transmembrane domain (185–208). |
| J24 | LINF_300022800 | 740 | 27–93 | 135–179 | - | II | - |
| J25 | LINF_260017700 | 898 | 459–525 | 535–551 | - | II | J-domain in the middle. |
| J26 | LINF_170005500 | 262 | 69–134 | - | - | III | Transmembrane domain (170–193). |
| J27 | LINF_040014400 | 493 | 92–158 | 164–194 | 253–331 | I | - |
| J28 | LINF_260017000 | 652 | 282–348 | 342–396 | - | II | J-domain in the middle. Transmembrane domains (12–35, 110–133, 139–162). |
| J29 | LINF_240016000 | 435 | 371–434 | - | - | III | J-domain at C-terminus. Transmembrane domain (268–291). |
| J30 | LINF_070013700 | 304 | - | - | - | - | Truncated. Lacking first 242 aa. |
| J31 | LINF_260014300 | 843 | 36–102 | - | - | IV | - |
| J32 | LINF_250029000 | 377 | 8–74 | 81–102 | 322–346 | I | - |
| J33 | LINF_360054000 | 275 | 7–73 | - | - | III | - |
| J34 | LINF_350052100 | 491 | 134–200 | - | - | III | Transmembrane domains (12–35, 112–132, 218–241). |
| J35 | LINF_140006000 | 523 | 377–443 | - | - | III | J-domain at C-terminus. |
| J36 | LINF_250023500 | 278 | 61–156 | - | - | III | - |
| J37 | LINF_180019800 | 1121 | 5–71 | - | - | III | - |
| J38 | LINF_300029900 | 336 | 15–81 | - | - | III | - |
| J40 | LINF_100017600 | 275 | 61–156 | - | - | III | - |
| J41 | LINF_310010500 | 603 | 288–354 | 373–396 | - | II | J-domain at the middle. |
| J42 | LINF_180022200 | 580 | 518–577 | - | - | III | J-domain at C-terminus. Tetratricopeptide (TPR)-like helical domain (135–272). |
| J43 | LINF_350045900 | 386 | 4–70 | - | - | III | - |
| J44 | LINF_310039900 | 217 | 18–84 | 105–148 | - | II | Transmembrane domains (121–144). |
| J45 | LINF_320040500 | 400 | 57–123 | 121–150 | 176–259 | I | Transmembrane domain (12–32). |
| J46 | LINF_250017100 | 396 | 57–123 | 123–150 | 175–258 | I | Transmembrane domains (8–31). |
| J47 | LINF_200010900 | 545 | 68–134 | - | 257–335 | IV | - |
| J49 | LINF_300015900 | 423 | 70–136 | - | - | III | Prokaryotic lipoprotein domain (1–33). |
| J50 | LINF_350035100 | 478 | 47–113 | 119–159 | 185–270 | I | - |
| J51 | LINF_340029700 | 808 | 700–766 | 779–807 | - | II | J-domain at C-terminus. TPR region (345–471, 572–677). TPR domain (345–378, 384–417, 610–643, 644–677). |
| J52 | LINF_360010300 | 510 | 386–452 | 461–509 | - | II | J-domain at C-terminus. TPR region (17–118, 254–359). TPR domain (17–50, 51–84, 208–241, 254–287, 326–359). |
| J53 | LINF_140019700 | 574 | 433–499 | 525–555 | - | II | J-domain at C-terminus. Transmembrane domain (20–43). TPR region (51–120, 223–290). |
| J54 | LINF_330016300 | 581 | 3–69 | - | - | II | Transmembrane domains (90–113, 129–152, 156–179, 198–221, 240–263, 269–292, 416–439, 459–482). |
| J55 | LINF_280018500 | 470 | 9–75 | - | - | III | - |
| J56 | LINF_330036200 | 266 | 77–133 | - | - | III | - |
| J57 | LINF_290026500 | 396 | 9–67 | 144–193 | - | II | - |
| J58 | LINF_240018200 | 808 | 5–68 | - | - | III | - |
| J59 | LINF_300027500 | 2451 | 1384–1450 | - | - | III | 2 GYF domain 2 (1059–1109). |
| J60 | LINF_090022000 | 413 | 42–108 | - | - | III | Prokaryotic lipoprotein domain (1–28). |
| J61 | LINF_080011700 | 296 | 3–69 | - | - | III | - |
| J62 | LINF_340005300 | 679 | 95–161 | - | - | III | Transmembrane domains (66–89, 174–197, 209–232). |
| J63 | LINF_320011200 | 316 | 42–108 | - | - | III | Transmembrane domain (278–301). |
| J64 | LINF_070013600 | 417 | 170–252 | - | - | III | J-domain in the middle. Transmembrane domain (362–385). |
| J65 | LINF_340046400 | 690 | 616–682 | - | - | III | J-domain at C-terminus. TPR-like helical domain (449–560). |
| J66 | LINF_220005800 | 331 | 185–275 | - | 52–139 | IV | - |
| J67 | LINF_360013200 | 850 | 733–843 | - | - | III | J-domain at C-terminus. TPR region (232–333, 569–640). TPR domain (232–265, 569–602, 607–640). |
| J68 | LINF_240025300 | 121 | 54–120 | - | - | IV | - |
| J69 | LINF_360059200 | 346 | 19–77 | - | - | III | - |
| J71 | LINF_240005500 | 439 | 50–105 | - | - | III | Transmembrane domain (318–337). |
| J72 | LINF_350036200 | 428 | 20–86 | - | - | III | Transmembrane domain (147–170). |
| J73 | LINF_260031000 | 488 | 31–84 | - | - | III | - |
| J74 | LINF_280025400 | 578 | 66–119 | - | - | III | - |
| J75 | LINF_350007400 | 368 | 216–282 | - | 37–60 | IV | J-domain at C-terminus. C3H1-type zinc finger (37–60). |
| J76 | LINF_140005800 | 384 | 60–123 | - | - | III | TPR region (1–31). |
| J77 | LINF_250010800 | 197 | 79–148 | - | - | IV | Transmembrane domain (160–183). |
a Data included in this column were obtained by using PROSITE (https://prosite.expasy.org/, accessed on 22 April 2022) or InterPro (https://www.ebi.ac.uk/interpro/, accessed on 22 April 2022) tools and from searching in public databases: PantherDB (http://www.pantherdb.org/, accessed on 22 April 2022), TriTrypDB (https://tritrypdb.org/, accessed on 22 April 2022) and UniProt (https://www.uniprot.org/, accessed on 22 April 2022).
Leishmania HSP40 members with possible orthologs in human and/or yeast.
| Name | Ortholog [References] | Suggested Cellular Location a | Identity (%) |
|---|---|---|---|
| J2 | DNAJA1, DNAJA4, mas5 [ | Glycosome, nucleolus | 44.70-44.02 |
| J3 | DNAJA2 [ | Glycosome | 42.35 |
| J4 | DNAJA1, DNAJA4 [ | Nucleolus | 29.76, 31.97 |
| J6 | SIS1, DNAJB1, DNAJB4, DNAJB5 [ | Glycosome, nucleus | 35.03-38.83 |
| J7 | DNAJB4, DNAJB5, DNAJB1 [ | - | 33.24-32.16 |
| J8 | - | Glycosome | - |
| J10 | Sec63 [ | Endoplasmic reticulum (ER), nucleus | 3.69 |
| J11 | - | Ciliary pocket | - |
| J13 | DNAJC24 [ | Cytoskeleton | 27.38 |
| J14 | DNAJC8, SPF31 [ | Nucleus | 40.35, 29.41 |
| J16 | DNAJC2, zuotin [ | Ribosome-associated complex | 27.22, 35.89 |
| J22 | pi041, C17A3.05c, DNAJB12 [ | ER membrane | 27.51-28.57 |
| J27 | DNAJA3 [ | Mitochondrion, glycosome | 33.77 |
| J31 | DNAJC11, SPCC63.03 [ | Mitochondrion | 32.20, 27.27 |
| J32 | DNAJC21, JJJ1 [ | - | 40.34, 31.46 |
| J33 | DNAJC9, C1071.09c [ | Nucleus, histone-related function | 29.92, 31.25 |
| J34 | Sec63 [ | ER membrane | 31.10 |
| J36 | DNAJC20/HscB, JAC1 [ | Mitochondrion | 26.56, 23.61 |
| J45 | DNAJA2, SCJ1 [ | ER | 31.69, 31.40 |
| J46 | DNAJA2, SCJ1 [ | ER | 36.36, 30.66 |
| J47 | DNAJA3, MDJ1 [ | Mitochondrion | 24.79, 27.42 |
| J50 | DNAJA2, SPJ1, SCJ1 [ | Glycosome | 37.57-30.65 |
| J51 | DNAJC7 [ | Ciliary basal body | 28.07 |
| J52 | DNAJC7 [ | - | 32.77 |
| J53 | DNAJC3 (ERdj6), JEM1 [ | ER | 28.71, 38.94 |
| J54 | - | Flagellum, Glycosome | - |
| J56 | DNAJC8 [ | Nucleus | 36.17 |
| J59 | DNAJC13, RME-8 [ | Endosome | 34.63, 34.63 |
| J60 | JJJ2v | - | 38.89 |
| J66 | DNAJA2 [ | ER | 43.46 |
| J68 | DNAJC15 (tim complex) [ | Mitochondrion | 29.41 |
a Proposed cellular locations are based on the location determined for ortholog proteins and/or data-derived from published proteomic studies in Leishmania [60,67,68,69,70,71,72].